Hypotonic Lysis for AAV Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The current viral production procedure for adeno-associated virus (AAV) is time-consuming and costly, primarily due to the use of the freeze-thaw (FT) lysis method for purification, which is inefficient and results in high production costs.
Innovation Solution
A method involving hypotonic lysis of AAV-producing cell cultures using nuclease-free water to release rAAV particles, followed by filtration, centrifugation, and resuspension in a buffer to obtain purified rAAV particles, reducing the production time and cost.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If freeze-thaw lysis method is used for AAV purification, then viral particles can be released from cells, but the production time is extended to eight days and production cost increases
Solution Approach 1:
The patent changes the lysis method from freeze-thaw to hypotonic lysis using nuclease-free water, altering the physical-chemical parameters of the cell lysis process. This parameter change reduces production time from eight days to less than five days while maintaining effective viral particle release, thereby improving productivity without significantly increasing production cost
Solution Approach 2:
The patent replaces the mechanical freeze-thaw lysis system with a chemical hypotonic lysis system using nuclease-free water. This substitution eliminates the need for repeated freezing and thawing cycles, reducing production time and simplifying the manufacturing process while achieving comparable purification results
2Productivity
If freeze-thaw lysis method is used, then AAV particles can be purified, but the process is time-consuming and inefficient
Solution Approach 1:
The patent changes the lysis parameters from temperature-based freeze-thaw cycles to osmotic pressure-based hypotonic lysis using nuclease-free water. This parameter change accelerates the cell lysis process, reducing purification time while maintaining high viral particle release efficiency, thus resolving the contradiction between purification efficiency and time loss
Solution Approach 2:
The patent applies hypotonic lysis treatment to cells before harvesting, which preliminarily breaks down cell structures and facilitates easier release of viral particles. This preliminary action streamlines subsequent purification steps, improving overall productivity without requiring extended processing time
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method significantly reduces the time required for AAV production from eight days to less than five days, achieving comparable viral titers and purity to the FT lysis method, while being more cost-effective and efficient.
Implementation Method 1
contacting said AAV-producing cells with nuclease-free water results in swelling of said AAV cells due to osmosis
Data Source
AI summary
Disclosed is a method of purifying recombinant adeno-associated virus (rAAV) particles. For instance, the rAAV particles may be derived from an AAV-producing cell culture. According to the present disclosure, the method can include a) producing a crude cell lysate comprising rAAV particles by hypotonic lysing of the cell culture; b) clarifying the crude cell lysate using filtration producing a supernatant comprising rAAV particles; c) isolating the supernatant to obtain a virus pellet comprising rAAV particles; and d) resuspending the virus pellet with a buffer to obtain purified rAAV particles.